Apomorphine in Parkinson's Disease Patients With Visual Hallucinations
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This randomised, double-blind, placebo-controlled trial will evaluate the efficacy of
continuous apomorphine infusion compared to placebo in PD patients with visual
hallucinations, inadequately controlled with clozapine and cholinesterase inhibitors.